MedPath

University of Kansas Medical Center

University of Kansas Medical Center logo
🇺🇸United States
Ownership
Private
Established
1906-01-01
Employees
5K
Market Cap
-
Website
https://www.kumc.edu

Blood Flow Responses to an Oral Glucose Tolerance Test in Type 2 Diabetes

Not Applicable
Completed
Conditions
Type 2 Diabetes
Insulin Resistance
Interventions
Behavioral: Exercise
First Posted Date
2009-09-07
Last Posted Date
2015-09-24
Lead Sponsor
University of Kansas Medical Center
Target Recruit Count
30
Registration Number
NCT00972452
Locations
🇺🇸

University of Kansas Medical Center, Kansas City, Kansas, United States

Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression

Phase 2
Completed
Conditions
Breast Cancer
Interventions
Biological: Growth Factor Support
Procedure: Surgery
First Posted Date
2009-07-22
Last Posted Date
2018-04-23
Lead Sponsor
University of Kansas Medical Center
Target Recruit Count
32
Registration Number
NCT00944047
Locations
🇺🇸

University of Kansas Medical Center Cancer Center, Kansas City, Kansas, United States

🇺🇸

Hays Medical Center, Hays, Kansas, United States

A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma

Phase 1
Terminated
Conditions
Renal Cell Carcinoma
Interventions
First Posted Date
2009-07-08
Last Posted Date
2017-06-14
Lead Sponsor
University of Kansas Medical Center
Target Recruit Count
11
Registration Number
NCT00934440
Locations
🇺🇸

Stormont-Vail Cotton O'Neil Cancer Center, Topeka, Kansas, United States

🇺🇸

University of Kansas Medical Center, Kansas City, Kansas, United States

Does Peri-Operative Gabapentin Reduce Chronic Post-Thoracotomy Pain?

Phase 3
Withdrawn
Conditions
Post-thoracotomy Pain
Interventions
Drug: Placebo
First Posted Date
2009-07-08
Last Posted Date
2015-12-16
Lead Sponsor
University of Kansas Medical Center
Registration Number
NCT00934193

Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.

Phase 2
Completed
Conditions
Invasive Breast Cancer
Interventions
Drug: Anastrazole
First Posted Date
2009-06-16
Last Posted Date
2023-05-19
Lead Sponsor
University of Kansas Medical Center
Target Recruit Count
42
Registration Number
NCT00921115
Locations
🇺🇸

University of Kansas Medical Center, Kansas City, Kansas, United States

Physical Activity and Glycemic Control

Not Applicable
Completed
Conditions
Insulin Resistance
Interventions
Behavioral: Exercise
First Posted Date
2009-04-16
Last Posted Date
2015-09-24
Lead Sponsor
University of Kansas Medical Center
Target Recruit Count
12
Registration Number
NCT00881972
Locations
🇺🇸

University of Missouri-Columbia, Columbia, Missouri, United States

Evaluate Rituximab in Obtaining PCR (Polymerase Chain Reaction) Negative Leukapheresis Product in Patients With Relapsed Follicular Lymphoma

Phase 2
Completed
Conditions
Non-Hodgkins Lymphoma
Interventions
First Posted Date
2009-03-05
Last Posted Date
2017-05-30
Lead Sponsor
University of Kansas Medical Center
Target Recruit Count
21
Registration Number
NCT00856245
Locations
🇺🇸

University of Kansas Medical Center, Westwood Campus, Kansas City, Kansas, United States

🇺🇸

University of Kansas Medical Center, Kansas City, Kansas, United States

Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2009-03-02
Last Posted Date
2018-01-17
Lead Sponsor
University of Kansas Medical Center
Target Recruit Count
25
Registration Number
NCT00853996
Locations
🇺🇸

University of Kansas Medical Center, Kansas City, Kansas, United States

Trial Comparing Outcomes With Merocel Packing or Thrombin-JMI for Anterior Epistaxis

Not Applicable
Terminated
Conditions
Epistaxis
Interventions
Drug: Merocel pack
First Posted Date
2008-12-24
Last Posted Date
2016-01-15
Lead Sponsor
University of Kansas Medical Center
Target Recruit Count
1
Registration Number
NCT00814333
Locations
🇺🇸

University of Kansas Medical Center, Kansas City, Kansas, United States

Efficacy of Methotrexate in Myasthenia Gravis

Phase 2
Completed
Conditions
Myasthenia Gravis
Interventions
Other: Placebo
First Posted Date
2008-12-24
Last Posted Date
2016-05-26
Lead Sponsor
University of Kansas Medical Center
Target Recruit Count
50
Registration Number
NCT00814138
Locations
🇺🇸

University of California-Irvine, Irvine, California, United States

🇺🇸

Penn State College of Medicine, The Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

🇺🇸

University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States

and more 13 locations
© Copyright 2025. All Rights Reserved by MedPath